These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6260267)

  • 1. Effect of ascorbate on abnormal neutrophil, platelet and lymphocytic function in a patient with the Chediak-Higashi syndrome.
    Weening RS; Schoorel EP; Roos D; van Schaik ML; Voetman AA; Bot AA; Batenburg-Plenter AM; Willems C; Zeijlemaker WP; Astaldi A
    Blood; 1981 May; 57(5):856-65. PubMed ID: 6260267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of leukocyte function in Chediak-Higashi syndrome by ascorbate.
    Boxer LA; Watanabe AM; Rister M; Besch HR; Allen J; Baehner RL
    N Engl J Med; 1976 Nov; 295(19):1041-5. PubMed ID: 184391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ascorbic acid in Chediak-Higashi syndrome (CHS): studies in humans and mice.
    Gallin JI; Elin RJ; Hubert RT; Fauci AS; Kaliner MA; Wolff SM
    Blood; 1979 Feb; 53(2):226-34. PubMed ID: 216437
    [No Abstract]   [Full Text] [Related]  

  • 4. Ascorbate and Chediak-Higashi syndrome.
    Nutr Rev; 1977 Jul; 35(7):170-2. PubMed ID: 197455
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prolonged remission of infectious symptoms during treatment with ascorbate in a case of Chediak-Higashi syndrome].
    Monciotti C; Colleselli P; Barbato A; Formentin E
    Pediatr Med Chir; 1983; 5(5):433-6. PubMed ID: 6544429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic nucleotides and the Chediak-Higashi syndrome.
    Zurier RB
    Adv Cyclic Nucleotide Res; 1980; 12():173-9. PubMed ID: 6250351
    [No Abstract]   [Full Text] [Related]  

  • 7. Abnormal platelet function in Chediak-Higashi syndrome.
    Boxer GJ; Holmsen H; Robkin L; Bang NU; Boxer LA; Baehner RL
    Br J Haematol; 1977 Apr; 35(4):521-533. PubMed ID: 194620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective lymphocyte locomotion in Chédiak-Higashi syndrome.
    Yeğin O; Sanal O; Yeralan O; Gürgey A; Berkel AI
    Am J Dis Child; 1983 Aug; 137(8):771-3. PubMed ID: 6869338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of Chediak-Higashi leukocyte function by cyclic guanosine monophosphate.
    Boxer LA; Rister M; Allen JM; Baehner RL
    Blood; 1977 Jan; 49(1):9-17. PubMed ID: 187266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet function in the Chediak-Higashi syndrome.
    Buchanan GR; Handin RI
    Blood; 1976 Jun; 47(6):941-8. PubMed ID: 1276475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane fluidity in human and mouse Chediak-Higashi leukocytes.
    Haak RA; Ingraham LM; Baehner RL; Boxer LA
    J Clin Invest; 1979 Jul; 64(1):138-44. PubMed ID: 221541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of the accelerated phase during ascorbic acid therapy in Chediak-Higashi syndrome and efficacy of colchicine on its management.
    Saitoh H; Komiyama A; Norose N; Morosawa H; Akabane T
    Br J Haematol; 1981 May; 48(1):79-84. PubMed ID: 7248192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes.
    Root RK; Rosenthal AS; Balestra DJ
    J Clin Invest; 1972 Mar; 51(3):649-65. PubMed ID: 4400956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The storage pool deficiency in platelets from humans with the Chédiak-Higashi syndrome: study of six patients.
    Apitz-Castro R; Cruz MR; Ledezma E; Merino F; Ramirez-Duque P; Dangelmeier C; Holmsen H
    Br J Haematol; 1985 Mar; 59(3):471-83. PubMed ID: 2982391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired microtubule function correctable by cyclic GMP and cholinergic agonists in the Chediak-Higashi syndrome.
    Oliver JM
    Am J Pathol; 1976 Nov; 85(2):395-418. PubMed ID: 187062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disorders of phagocyte function: biochemical aspects.
    Quie PG
    Prog Clin Biol Res; 1977; 13():157-69. PubMed ID: 45476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of levamisole on normal and abnormal leukocyte locomotion.
    Wright DG; Kirkpatrick CH; Gallin JI
    J Clin Invest; 1977 May; 59(5):941-50. PubMed ID: 192765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of the Steinbrinck-Chediak-Higashi-Syndrom (author's transl)].
    Rister M; Haneke C
    Klin Padiatr; 1980 Jan; 192(1):19-24. PubMed ID: 7188986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet aggregation, storage pool deficiency, and protein phosphorylation in mice with Chediak-Higashi syndrome.
    Pratt HL; Carroll RC; Jones JB; Lothrop CD
    Am J Vet Res; 1991 Jun; 52(6):945-50. PubMed ID: 1652907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulated neutrophil locomotion: chemokinesis and chemotaxis.
    Becker EL
    Arch Pathol Lab Med; 1977 Oct; 101(10):509-13. PubMed ID: 199132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.